Melanotan II (10 mg Vial) & PT-141 (10 mg Vial) Dosage Protocol

Quickstart Highlights

Stack Melanotan II and PT-141 for synergistic tanning and libido enhancement.

Melanotan II: 0.25–0.5 mg per injection, 2×/week for 4 weeks
PT-141: 1.75 mg per injection, as-needed (max 1/24 h, ≤ 8/mo)
Typical Melanotan II cycle: 4 weeks; PT-141 is on-demand
Reconstitute each vial with bacteriostatic water (max 3 mL)
Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Melanotan II (10 mg Vial) & PT-141 (10 mg Vial)

Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Melanotan II (10 mg Vial): Standard/Gradual Approach

Reconstitute with 3 mL bacteriostatic water → 3.33 mg/mL. (Max 3 mL per vial.)

Week	Dosage	Units (mL)	Frequency
Weeks 1–2	250 mcg (0.25 mg)	~7.5 units (0.075 mL) use 30 or 50-unit syringe	2× per week
Weeks 3–4	500 mcg (0.5 mg)	~15 units (0.15 mL)	2× per week

Note: Even at 3 mL dilution, Week 1 injections are <10 units; a smaller (30/50-unit) syringe improves accuracy.

Draw 3.0 mL bacteriostatic water into a sterile syringe.
Inject slowly against vial wall; avoid vigorous shaking.
Swirl gently until dissolved; label with date.
Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

PT-141 (10 mg Vial): On-Demand Protocol

Reconstitute with 1 mL bacteriostatic water → 10 mg/mL.

Use Case	Dosage	Units (mL)	Frequency
Female HSDD	1.75 mg (1750 mcg)	~18 units (0.18 mL)	As needed, ≥45 min before sex Max 1/24 h, ≤ 8/mo
Male ED (off-label)	1.0–2.0 mg	10–20 units	As needed, 30–60 min before sex Max 1/24 h, ≤ 8/mo

Alternatively, split into 1 mg (50 units) twice weekly.

Draw 1.0 mL bacteriostatic water into a sterile syringe.
Inject gently; swirl to dissolve; label and refrigerate.
Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Stack Administration

Administer both peptides on same day if desired—use separate syringes and injection sites; do not mix in one syringe.

Melanotan II injections on two consistent days/week (e.g., Mon & Thu)
PT-141 on-demand before sexual activity
Maintain injection logs to track dose and effects

Combining CJC-1295 DAC & Ipamorelin in a Stack

Administer both peptides on the same protocol day:

CJC-1295 DAC: 1–2 mg weekly (see approach tables)
Ipamorelin: 200–300 μg/day (1×–2× daily)
Use separate syringes and injection sites; do not mix in one vial

Note: This guide is for educational purposes only. Always consult a qualified professional.

Supplies Needed

Materials for a 4-week Melanotan II cycle + PT-141.

Peptide Vials:
• Melanotan II (10 mg Vial) – Product ID: 1049 (need 2 vials for 4-wk cycle)
• PT-141 (10 mg Vial) – Product ID: 1044 (1 vial covers ≤ 8 doses)
Insulin Syringes: 30-unit & 100-unit sizes
Bacteriostatic Water: 1× 30 mL bottle
Alcohol Swabs: 1 box

Protocol Overview

4-week tanning cycle with Melanotan II plus on-demand PT-141 for libido.

Melanotan II: 0.25–0.5 mg/inj, 2× weekly
PT-141: 1.75 mg/inj, as needed (max 1/24 h, ≤ 8/mo)
Cycle Length: Melanotan II: 4 weeks; PT-141: flexible
Reconstitution: Melanotan II: 3 mL; PT-141: 1 mL

Dosing Protocol

Method: Subcutaneous or IM, rotate sites
CJC-1295: Once weekly (Monday preferred)
Ipamorelin: Once or twice daily (e.g., AM & bedtime)
Timing: Separate syringes; can align with meals or sleep
Duration: 4–6 weeks per cycle

Storage Instructions

Preserve potency by proper handling.

Lyophilized: Keep frozen until reconstitution
Reconstituted: Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Important Notes

Safety and consistency tips.

Use new, sterile syringes each injection; rotate sites.
Keep detailed injection log (dose, date, effects).
Monitor for nausea, flushing, blood pressure changes.
Do not mix peptides in same syringe.

How This Works

Peptide actions underpin protocol.

Melanotan II: Activates MC1R → melanin synthesis (tanning), MC3/4R → libido effects.
PT-141: Activates MC4R in CNS → sexual arousal and desire.
Separate mechanisms yield complementary outcomes.

Potential Benefits & Side Effects

Research-backed outcomes with caution.

Enhanced baseline tan; reduced UV damage sensitivity
Improved sexual desire and erectile function
Mild side effects: nausea, facial flushing, headache
Monitor for pigment changes (moles), blood pressure elevations

Injection Technique

Simple guidelines for safe daily injections.

Clean vial rubber stopper & injection site with alcohol swabs
Insert needle at a 45–90° angle into subcutaneous tissue
Inject slowly & rotate sites (abdomen, thigh, etc.)

Lifestyle Factors

Complementary strategies for best outcomes.

Maintain a protein-rich diet and stay hydrated
Engage in regular exercise; allow adequate rest
Manage stress and prioritize quality sleep

Recommended Source

We recommend Pure Lab Peptides for high-purity BPC-157 + TB-500 blend.

Why Pure Lab Peptides?

Verifies ≥99% purity through independent lab testing
Trusted by researchers seeking reliable results
Follows rigorous manufacturing standards for consistent quality

Shop at Pure Lab Peptides

Important Note

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References

PubMed

– Melanotan II phase-I human study

PubMed

– Bremelanotide early clinical efficacy trial

PMC

– Bremelanotide Phase-3 HSDD review

FDA Document

– Bremelanotide NDA 210557 package

ClinicalTrials.gov

– PT-141 efficacy registry study

ScienceDirect

– Melanotan II pharmacology article

British J Dermatology

— JPT Peptide Technologies Blog (2023)

Karger Dermatology

– Melanotan II user-experience study

ScienceDirect

– Peptide pharmacokinetics research article

Taylor & Francis

– Pharmaceutical medicine review on MT-2

PubMed

– Injection-site technique safety review

ScienceDirect

– Subcutaneous delivery factors study